The Jason Wright Show cover image

Semaglutide, Ozempic, Terzepetide Weight Loss MasterClass With Dr. Gus Vickery, M.D.

The Jason Wright Show

NOTE

The Potential of Semaglutide and Tirzepatide as Peptides for Diabetes and Obesity

To zepatide, a phenomenal but expensive peptide, is a dual GLP1 and GIP agonist with a powerful impact on appetite and less intense side effects compared to semaglutide. It is expected to gain popularity when it receives its obesity indication.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner